Floatz logo

Ursodeoxycholic Acid

Cirrhosis Of Liver

Chang Gung Memorial HospitalSmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

133 Active assets in the Cirrhosis Of Liver cohort.

Asset / SponsorPhaseRating
Veruprevir
AbbVie
Phase 3A
Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-Nh2 (4-9 Disulfide)
General Hospital of Shenyang Military Region
Phase 4BBB
Tolvaptan
Institute of Liver and Biliary Sciences, India
Phase 4BBB
Ribavirin
Peking University People's Hospital
Phase 4BBB
NORMAL HUMAN SERUM ALBUMIN
King George's Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Ursodeoxycholic Acid is also rated in:

primary biliary cholangitisActive
A
Indicative · Phase 4
82 / 100
View asset →
type 2 diabetes mellitusDormant
BB
Indicative · Phase 4
71 / 100
View asset →
cholestasisDormant
BB
Indicative · Phase 3
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →